文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

All You Need to Know About TACE: A Comprehensive Review of Indications, Techniques, Efficacy, Limits, and Technical Advancement.

作者信息

Lanza Carolina, Ascenti Velio, Amato Gaetano Valerio, Pellegrino Giuseppe, Triggiani Sonia, Tintori Jacopo, Intrieri Cristina, Angileri Salvatore Alessio, Biondetti Pierpaolo, Carriero Serena, Torcia Pierluca, Ierardi Anna Maria, Carrafiello Gianpaolo

机构信息

Department of Diagnostic and Interventional Radiology, Foundation IRCCS Cà Granda-Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy.

Postgraduate School in Radiodiagnostics, Università degli Studi di Milano, 20122 Milan, Italy.

出版信息

J Clin Med. 2025 Jan 7;14(2):314. doi: 10.3390/jcm14020314.

DOI:10.3390/jcm14020314
PMID:39860320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11766109/
Abstract

Transcatheter arterial chemoembolization (TACE) is a proven and widely accepted treatment option for hepatocellular carcinoma and it is recommended as first-line non-curative therapy for BCLC B/intermediate HCC (preserved liver function, multifocal, no cancer-related symptoms) in patients without vascular involvement. Different types of TACE are available nowadays, including TAE, c-TACE, DEB-TACE, and DSM-TACE, but at present there is insufficient evidence to recommend one TACE technique over another and the choice is left to the operator. This review then aims to provide a comprehensive overview of the current literature on indications, types of procedures, safety, and efficacy of different TACE treatments.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a237/11766109/405260f85155/jcm-14-00314-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a237/11766109/29025a1b8522/jcm-14-00314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a237/11766109/eb75a29ae5ca/jcm-14-00314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a237/11766109/a6930dbaa19a/jcm-14-00314-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a237/11766109/405260f85155/jcm-14-00314-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a237/11766109/29025a1b8522/jcm-14-00314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a237/11766109/eb75a29ae5ca/jcm-14-00314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a237/11766109/a6930dbaa19a/jcm-14-00314-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a237/11766109/405260f85155/jcm-14-00314-g004.jpg

相似文献

[1]
All You Need to Know About TACE: A Comprehensive Review of Indications, Techniques, Efficacy, Limits, and Technical Advancement.

J Clin Med. 2025-1-7

[2]
Multifocal hepatocellular carcinoma: a narrative review assessing treatment options from the interventional radiologist's perspective.

Ann Palliat Med. 2023-11

[3]
Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis.

J Cancer Res Clin Oncol. 2024-5-6

[4]
5-Fluorouracil combined with CalliSphere drug-eluting beads or conventional transarterial chemoembolization for unresectable hepatocellular carcinoma: a propensity score weighting analysis.

Sci Rep. 2024-10-26

[5]
Transarterial Chemoembolization and Unresectable Hepatocellular Carcinoma: A Narrative Review.

Cureus. 2022-8-26

[6]
Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in the Downstaging of Intermediate-Stage Hepatocellular Carcinoma (HCC) in Patients With a Child-Pugh Score of 8-9.

Front Pharmacol. 2021-4-8

[7]
Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.

J Cancer Res Ther. 2021-7

[8]
Transarterial chemoembolization (TACE) in the management of hepatocellular carcinoma: Results of a French national survey on current practices.

Diagn Interv Imaging. 2018-3-30

[9]
Safety and Long-Term Survival Outcome in Patients With Unresectable Barcelona Clinic Liver Cancer (BCLC) Stages C and D Advanced Hepatocellular Carcinoma Treated With 40 μm Drug-Eluting Bead Transcatheter Arterial Chemoembolization.

Cureus. 2022-4-11

[10]
Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.

Cardiovasc Intervent Radiol. 2019-10-23

引用本文的文献

[1]
Management of hepatocellular carcinoma prior to liver transplantation: latest developments.

Hepat Oncol. 2025-12

[2]
Application of Nanotechnology in TACE Treatment of Liver Cancer.

Int J Nanomedicine. 2025-8-4

[3]
Neuroendocrine Neoplasms in Pregnancy: A Narrative Review of Clinical Challenges and Therapeutic Limitations in the Absence of Established Safe Treatments.

J Pers Med. 2025-6-25

[4]
Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

J Gastrointest Cancer. 2025-7-23

[5]
Determinants of Health-Related Quality of Life After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients: A Systematic Review.

J Clin Med. 2025-6-3

[6]
Endoscopic management of pancreatic and biliary duct stenoses due to a giant pseudoaneurysm in a patient clinically suggestive of Loeys-Dietz syndrome.

Clin J Gastroenterol. 2025-5-28

[7]
Harnessing Dendritic Cell Function in Hepatocellular Carcinoma: Advances in Immunotherapy and Therapeutic Strategies.

Vaccines (Basel). 2025-5-4

本文引用的文献

[1]
Embolization alone is as effective as TACE for unresectable HCC: systematic review and meta-analysis of randomized controlled trails.

BMC Gastroenterol. 2024-6-7

[2]
Which is the best TACE agent for patients with different NLR hepatocellular carcinomas? A systematic review and network meta-analysis.

Heliyon. 2024-5-4

[3]
Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis.

J Cancer Res Clin Oncol. 2024-5-6

[4]
Incidence and Risk Factors of Acute Ischemic Cholecystitis after Transarterial Chemoembolization: Correlation with Cone Beam CT Findings.

J Korean Soc Radiol. 2024-3

[5]
Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape.

Cancers (Basel). 2024-2-4

[6]
Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.

Radiology. 2023-11

[7]
A multi-institutional study to predict the benefits of DEB-TACE and molecular targeted agent sequential therapy in unresectable hepatocellular carcinoma using a radiological-clinical nomogram.

Radiol Med. 2024-1

[8]
Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.

Hepatol Commun. 2023-10-1

[9]
Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study.

Radiol Med. 2023-12

[10]
A multivariate model based on gadoxetic acid-enhanced MRI using Li-RADS v2018 and other imaging features for preoperative prediction of dual‑phenotype hepatocellular carcinoma.

Radiol Med. 2023-11

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索